Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

Valsamo Anagnostou(Bloomberg (United States)), Noushin Niknafs(Johns Hopkins University), Kristen A. Marrone(Bloomberg (United States)), Daniel C. Bruhm(Johns Hopkins University), James R. White(Johns Hopkins University), Jarushka Naidoo(Bloomberg (United States)), Karlijn Hummelink(The Netherlands Cancer Institute), Kim Monkhorst(The Netherlands Cancer Institute), Ferry Lalezari(The Netherlands Cancer Institute), Mara Lanis(Johns Hopkins University), Samuel Rosner(Johns Hopkins University), Joshua E. Reuss(Johns Hopkins University), Kellie N. Smith(Bloomberg (United States)), Vilmos Adleff(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University), Zineb Belcaid(Johns Hopkins University), Lamia Rhymee(Johns Hopkins University), Benjamin Levy(Bloomberg (United States)), Josephine Feliciano(Bloomberg (United States)), Christine L. Hann(Bloomberg (United States)), David S. Ettinger(Bloomberg (United States)), Christos Georgiades(Johns Hopkins University), Franco Verde(Johns Hopkins University), Peter B. Illei(Johns Hopkins University), Qing Kay Li(Johns Hopkins University), Alexander S. Baras(Johns Hopkins University), Edward Gabrielson(Johns Hopkins University), Malcolm V. Brock(Johns Hopkins University), Rachel Karchin(Johns Hopkins University), Drew M. Pardoll(Bloomberg (United States)), Stephen B. Baylin(Johns Hopkins University), Julie R. Brahmer(Bloomberg (United States)), Robert B. Scharpf(Johns Hopkins University), Patrick M. Forde(Bloomberg (United States)), Victor E. Velculescu(Bloomberg (United States))
Nature Cancer
January 13, 2020
Cited by 207Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis